— Know what they know.
Not Investment Advice
Also trades as: 0IGA.L (LSE) · $vol 0M

EBS Short Interest

Emergent BioSolutions Inc.
1W: +6.0% 1M: -2.8% 3M: -9.2% YTD: -46.7% 1Y: -31.5% 3Y: +201.8% 5Y: -86.9%
$6.67
+0.33 (+5.21%)
 
Weekly Expected Move ±10.7%
$5 $6 $6 $7 $8
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 40 · $342.0M mcap · 49M float · 2.26% daily turnover · Short 55% of daily vol
Credit Risk of going bust: higher than 91% of companies Debt: 63.0% of company value Bonds: $63.5M held by 75 funds, 397 bp over Treasuries → details ▾
Of US companies ranked in the riskiest tenth, about 1 in 20 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.14 (down 83%), Emergent BioSolutions Inc. would be worth roughly what it owes.
Total debt $581.8M against a stock market value of $342.0M.
Distance to default 1.50 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $290.9M (short-term plus half of long-term), stock volatility 81.1%; Altman Z 0.84. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Short Volume Summary

2026-10-26
49.2%
Short Ratio
of total volume
57.4%
20-Day Avg
58.0%
50-Day Avg
▼ Falling
5-Day Trend
0.1M
Short Volume
0.2M
Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-26
ExchangeShort VolumeTotal VolumeShort %
NASDAQ 76,899 154,413 49.8%
BATS 50 2,031 2.5%
NYSE 823 1,691 48.7%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms